Examination of remission period in ulcerative colitis patients led to mucosal remission by induction therapy with budesonide rectal foam (AJG511) .
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Dec 2018
At a glance
- Drugs Budesonide (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms ESCORT
- Sponsors EA Pharma; Kissei Pharmaceutical
- 06 Dec 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 03 Apr 2018 New trial record